Shuttle Pharmaceuticals Inc

Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company that develops novel therapies for cancer treatment. It owns an artificial intelligence (AI)-driven pharmaceutical software platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.